Berman Robert
Special Projects & Med Ovrsght at Biohaven Pharmaceutical Holding Co Ltd.
- Sold, on record
- $30.6M
- Dollars the filings state
- Form 4 sales
- 14
- Latest Jul 8, 2020
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Biohaven Pharmaceutical Holding Co Ltd.Special Projects & Med Ovrsght
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.Plan not statedApr 10 2018
Sold 35,000 shares at $24.66 ($863k)
Berman Robert, Chief Medical Officer
Sold 8.5% of holdings ($10.1M position)376,000 shares left1x usual sizeFiling
- 2 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.Plan not statedMay 10 +30 days
Sold 35,000 shares at $26.82 ($939k)
Berman Robert, Chief Medical Officer
Sold 9.1% of holdings ($10.3M position)348,000 shares left1x usual sizeFiling
- 3 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.Plan not statedJun 7 +28 days
Sold 25,845 shares at $36.01 ($931k)
Berman Robert, Chief Medical Officer
Sold 7.3% of holdings ($12.7M position)327,427 shares left0.7x usual sizeFiling
- 4 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.UnusualJun 12 +5 days
Sold 104,155 shares at $36.33 ($3.8M)
Berman Robert, Chief Medical Officer
Sold 30.8% of holdings ($12.3M position)234,551 shares left3x usual sizeFiling
- 5 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.UnusualDec 30 +566 days
Sold 125,000 shares at $53.22 ($6.7M)
Berman Robert, Special Projects & Med Ovrsght
Sold 99.7% of holdings ($6.7M position)341 shares left3.6x usual sizeFiling
- 6 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.UnusualJun 19 +172 days
Sold 62,300 shares at $75.27 ($4.7M)
Berman Robert, Special Projects & Med Ovrsght
Sold 99.5% of holdings ($4.7M position)341 shares leftFiling
- 7 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.UnusualJun 23 +4 days
Sold 4,296 shares at $75.05 ($322k)
Berman Robert, Special Projects & Med Ovrsght
Sold 92.6% of holdings ($348k position)341 shares leftFiling
- 8 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.UnusualJul 8 +15 days
Sold 58,404 shares at $75.25 ($4.4M)
Berman Robert, Special Projects & Med Ovrsght
Sold 99.4% of holdings ($4.4M position)341 shares left0.9x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (14)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jul 8, 2020 | Biohaven Pharmaceutical Holding Co Ltd. | Special Projects & Med Ovrsght | Form 4 sale | 58,404 | $4.4M | 99.4% | Unusual | SEC |
| Jun 23, 2020 | Biohaven Pharmaceutical Holding Co Ltd. | Special Projects & Med Ovrsght | Form 4 sale | 4,296 | $322k | 92.6% | Unusual | SEC |
| Jun 19, 2020 | Biohaven Pharmaceutical Holding Co Ltd. | Special Projects & Med Ovrsght | Form 4 sale | 62,300 | $4.7M | 99.5% | Unusual | SEC |
| Dec 30, 2019 | Biohaven Pharmaceutical Holding Co Ltd. | Special Projects & Med Ovrsght | Form 4 sale | 125,000 | $6.7M | 99.7% | Unusual | SEC |
| Jun 12, 2018 | Biohaven Pharmaceutical Holding Co Ltd. | Chief Medical Officer | Form 4 sale | 104,155 | $3.8M | 30.8% | Unusual | SEC |
| Jun 7, 2018 | Biohaven Pharmaceutical Holding Co Ltd. | Chief Medical Officer | Form 4 sale | 25,845 | $931k | 7.3% | Plan not stated | SEC |
| May 10, 2018 | Biohaven Pharmaceutical Holding Co Ltd. | Chief Medical Officer | Form 4 sale | 35,000 | $939k | 9.1% | Plan not stated | SEC |
| Apr 10, 2018 | Biohaven Pharmaceutical Holding Co Ltd. | Chief Medical Officer | Form 4 sale | 35,000 | $863k | 8.5% | Plan not stated | SEC |
| Mar 12, 2018 | Biohaven Pharmaceutical Holding Co Ltd. | Chief Medical Officer | Form 4 sale | 35,000 | $1.1M | 8.0% | Plan not stated | SEC |
| Feb 12, 2018 | Biohaven Pharmaceutical Holding Co Ltd. | Chief Medical Officer | Form 4 sale | 35,000 | $1.1M | 7.5% | Plan not stated | SEC |
| Jan 10, 2018 | Biohaven Pharmaceutical Holding Co Ltd. | Chief Medical Officer | Form 4 sale | 35,000 | $963k | 7.0% | Plan not stated | SEC |
| Dec 19, 2017 | Biohaven Pharmaceutical Holding Co Ltd. | Chief Medical Officer | Form 4 sale | 10,000 | $241k | 2.0% | Plan not stated | SEC |
| Dec 11, 2017 | Biohaven Pharmaceutical Holding Co Ltd. | Chief Medical Officer | Form 4 sale | 25,000 | $532k | 4.7% | Plan not stated | SEC |
| Nov 14, 2017 | Biohaven Pharmaceutical Holding Co Ltd. | Chief Medical Officer | Form 4 sale | 160,000 | $4.1M | 23.5% | Plan not stated | SEC |